2014 - 03 - 26
CRP-Santé enters into exclusive licensing agreement with Advanced Biological Laboratories (ABL) S.A. for “COMET” software a tool designed for high performance DNA sequencing analysis and classification
Luxembourg, March 26, 2014. CRP-Santé today announced that it has entered into an exclusive worldwide licensing agreement with ABL for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields. Integrated in the clinical management and diagnostics platforms of ABL, COMET will contribute to support the decision-making of healthcare professionals in their daily challenge of providing the best treatment adapted to each of their patients with viral and other infectious or chronic diseases.